Recently, we found that L1CAM is aberrantly expressed in biliary tract cancers such as ICC, ECC, and gall bladder carcinoma (GBC), and its high expression correlates with poor prognosis and metastasis [19–21]. Here, L1CAM is linked to biliary tract cancer.